Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Simon

Showing results (301-310 of 495) with videos related to

Pageof 50
Sort By:
Cancer Gene Therapy|January 8, 2021
CHD1 loss negatively influences metastasis-free survival in R0-resected prostate cancer patients and promotes spontaneous metastasis in vivoSu Jung Oh-Hohenhorst, Derya Tilki, Ann-Kristin Ahlers, et al.
The American Journal of Pathology|June 19, 2012
Genomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion-positive and fusion-negative prostate cancerAntje Krohn, Tobias Diedler, Lia Burkhardt, et al.
Virchows Archiv : an International Journal of Pathology|August 6, 2024
PAX8 expression in cancerous and non-neoplastic tissue: a tissue microarray study on more than 17,000 tumors from 149 different tumor entitiesNatalia Gorbokon, Sarah Baltruschat, Maximilian Lennartz, et al.
Gynecologic Oncology|January 12, 2020
High homogeneity of MMR deficiency in ovarian cancerChristoph Fraune, Janina Rosebrock, Ronald Simon, et al.
Aging|September 27, 2019
Up regulation of Rho-associated coiled-coil containing kinase1 (ROCK1) is associated with genetic instability and poor prognosis in prostate cancerStefan Steurer, Benjamin Hager, Franziska Büscheck, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 12, 2018
Identification of a High-Level MET Amplification in CTCs and cfTNA of an ALK-Positive NSCLC Patient Developing Evasive Resistance to CrizotinibLars-Arne Berger, Melanie Janning, Janna-Lisa Velthaus, et al.
Pathology, Research and Practice|July 25, 2022
Large-scale human tissue analysis identifies Uroplakin 1a as a putative diagnostic marker for urothelial cancerViktor Reiswich, Steffi Könemann, Maximilian Lennartz, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 25, 2021
Overexpression of the TRIM24 E3 Ubiquitin Ligase is Linked to Genetic Instability and Predicts Unfavorable Prognosis in Prostate CancerDoris Höflmayer, Christoph Fraune, Claudia Hube-Magg, et al.
Oncotarget|November 12, 2016
p16 overexpression and 9p21 deletion are linked to unfavorable tumor phenotype in breast cancerPatrick Lebok, Magdalena Roming, Martina Kluth, et al.
Nature Communications|December 23, 2025
Prostate cancer cells converge to an inflammatory-like state upon metastatic disseminationTina Keshavarzian, Kira Furlano, Giacomo Grillo, et al.
Pageof 50

Showing results (301-310 of 495) with videos related to

Sort By:
Pageof 50
Cancer Gene Therapy|January 8, 2021
CHD1 loss negatively influences metastasis-free survival in R0-resected prostate cancer patients and promotes spontaneous metastasis in vivoSu Jung Oh-Hohenhorst, Derya Tilki, Ann-Kristin Ahlers, et al.
The American Journal of Pathology|June 19, 2012
Genomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion-positive and fusion-negative prostate cancerAntje Krohn, Tobias Diedler, Lia Burkhardt, et al.
Virchows Archiv : an International Journal of Pathology|August 6, 2024
PAX8 expression in cancerous and non-neoplastic tissue: a tissue microarray study on more than 17,000 tumors from 149 different tumor entitiesNatalia Gorbokon, Sarah Baltruschat, Maximilian Lennartz, et al.
Gynecologic Oncology|January 12, 2020
High homogeneity of MMR deficiency in ovarian cancerChristoph Fraune, Janina Rosebrock, Ronald Simon, et al.
Aging|September 27, 2019
Up regulation of Rho-associated coiled-coil containing kinase1 (ROCK1) is associated with genetic instability and poor prognosis in prostate cancerStefan Steurer, Benjamin Hager, Franziska Büscheck, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 12, 2018
Identification of a High-Level MET Amplification in CTCs and cfTNA of an ALK-Positive NSCLC Patient Developing Evasive Resistance to CrizotinibLars-Arne Berger, Melanie Janning, Janna-Lisa Velthaus, et al.
Pathology, Research and Practice|July 25, 2022
Large-scale human tissue analysis identifies Uroplakin 1a as a putative diagnostic marker for urothelial cancerViktor Reiswich, Steffi Könemann, Maximilian Lennartz, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 25, 2021
Overexpression of the TRIM24 E3 Ubiquitin Ligase is Linked to Genetic Instability and Predicts Unfavorable Prognosis in Prostate CancerDoris Höflmayer, Christoph Fraune, Claudia Hube-Magg, et al.
Oncotarget|November 12, 2016
p16 overexpression and 9p21 deletion are linked to unfavorable tumor phenotype in breast cancerPatrick Lebok, Magdalena Roming, Martina Kluth, et al.
Nature Communications|December 23, 2025
Prostate cancer cells converge to an inflammatory-like state upon metastatic disseminationTina Keshavarzian, Kira Furlano, Giacomo Grillo, et al.
Pageof 50